Results 291 to 300 of about 281,052 (341)

Targeting the ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti‐VEGF resistance in endometrial cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate the role of ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) in endometrial cancer (EC) progression and its potential as a therapeutic target to enhance the efficacy of antiangiogenic treatment. Methods ST3Gal1 expression and its clinical relevance were analyzed in EC tissues.
Chia‐Hao Liu, Szu‐Ting Yang, Wei‐Ting Chao, Chen‐Hao Lin, Yu‐Chieh Lee, Chiung‐Ru Lai, Shie‐Liang Hsieh, Liang‐Wei Wang, Peng‐Hui Wang   +8 more
wiley   +1 more source

[Retracted] Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-κB-p53-caspase-3 pathway. [PDF]

Exp Ther Med
Dang YP, Yuan XY, Tian R, Li DG, Liu W.
europepmc   +1 more source

Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare overall survival (OS) in patients with high‐grade serous ovarian cancer (HGSOC) treated with intraperitoneal (IP) chemotherapy versus intravenous (IV) chemotherapy. Methods A retrospective study of Stage III HGSOC with optimal primary cytoreduction during 2007–2019, followed by adjuvant IP or IV chemotherapy.
Joshua S Cheruvathur, Gabriel Levin, Reitan Ribeiro, Florentin Racovitan, Joanne Power, Xing Zeng, John Sampalis, Lucy Gilbert   +7 more
wiley   +1 more source

Drug-Coated Balloon (Optilume®) for the Management of Bulbar Urethral Stricture, Our Experience. [PDF]

Urol Res Pract
Alnadhari I, Alshrani M, Alhattami A, Shanaa W, Ali O, Abdeljaleel O, Abukhadijah HJ, Shamsodini A.   +7 more
europepmc   +1 more source

Patient‐derived xenograft models in pan‐cancer: From bench to clinic

Interdisciplinary Medicine, EarlyView.
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li, Ao Gu, Nannan Tang, Gokhan Zengin, Meng‐Yao Li, Yingbin Liu   +5 more
wiley   +1 more source

A Novel HDAC6 Inhibitor Enhances the Efficacy of Paclitaxel Against Ovarian Cancer Cells. [PDF]

Molecules
Chi AJ, Hsu JL, Xiao YX, Chern JW, Guh JH, Yu CW, Hsu LC.   +6 more
europepmc   +1 more source

Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trial. [PDF]

BMJ Open
Zietse M, Aalders LC, Spierings LEAMM, De Rouw N, Dercksen W, Dalm VASH, Oomen-de Hoop E, Thielen FW, Koch BCP, Mathijssen RHJ, van Doorn L, Leeuwen RWFV.   +11 more
europepmc   +1 more source

The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer. [PDF]

Commun Biol
Ge Y, Kong L, Li Y, Yu Z, Zhai F, Zhan Z, Chen G, Wang S, Wang H, Wang Y, Zhao J, Hu L, Mao J, Wang S, Shi J, Zhao M, Lou P, Ye M, Jin X.   +18 more
europepmc   +1 more source

Higher Body Mass Index Is Related to Severe Chemotherapy-Induced Peripheral Neuropathy in Patients with Ovarian Cancer: A Preliminary Retrospective Study. [PDF]

J Clin Med
Park JM, Seo I, Kang M, Chong GO, Lee YH, Park JS.   +5 more
europepmc   +1 more source